Evidence map›Paper›PMID 33475833›Full record

ArticleLangenbeck's archives of surgery2021

Clinical impact of preoperative tumour contact with superior mesenteric-portal vein in patients with resectable pancreatic head cancer.

Fabio Ausania, Santiago Sanchez-Cabus, Paula Senra Del Rio, Alex Borin, Juan Ramon Ayuso, Pilar Bodenlle, Sofia Espinoza, Miriam Cuatrecasas, Carlos Conill, Tamara Saurí and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Langenbeck's archives of surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Fabio AusaniaDepartment of HPB and Transplant Surgery, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Santiago Sanchez-CabusDepartment of HPB and Transplant Surgery, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Paula Senra Del RioDepartment of HPB Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Alex BorinDepartment of HPB and Transplant Surgery, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain. alexborin.ab@gmail.com.ORCID http://orcid.org/0000-0001-8316-2459
Juan Ramon AyusoDepartment of Radiology, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.
Pilar BodenlleDepartment of Radiology, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Sofia EspinozaDepartment of HPB and Transplant Surgery, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Miriam CuatrecasasDepartment of Pathology, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.
Carlos ConillDepartment of Radiotherapy, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain.
Tamara SauríDepartment of Medical Oncology, Hospital Clinic and Department of Medicine, University of Barcelona, Barcelona, Spain.
Joana FerrerDepartment of HPB and Transplant Surgery, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Josep FusterDepartment of HPB and Transplant Surgery, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Juan Carlos García-ValdecasasDepartment of HPB and Transplant Surgery, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Reyes MelendezDepartment of HPB Surgery, Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
Constantino FondevilaDepartment of HPB and Transplant Surgery, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Hospital Clínic de Barcelona · ESUniversity Hospital Complex Of Vigo · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe NCCN classification of resectability in pancreatic head cancer does not consider preoperative radiological tumour ≤ 180° contact with portal vein/superior mesenteric vein (PV/SMV) as a negative prognostic feature. The aim of this study is to evaluate whether this factor is associated with higher rate of incomplete resection and poorer survival.

methodsAll patients considered for pancreatic resection between 2012 and 2017 at two Spanish referral centres were included. Patients with borderline and locally advanced pancreatic ductal adenocarcinoma (PDAC) according to NCCN classification were excluded. Preoperative CT scans were reviewed by dedicated radiologists to identify radiologic tumour contact with PV/SMV.

resultsOut of 302, 71 patients were finally included in this study. Twenty-two (31%) patients showed tumour-PV/SMV contact (group 1) and 49 (69%) did not show any contact (group 2). Patients in group 1 showed a statistically significantly higher rate of R1 and R1-direct margins compared with group 2 (95 vs 28% and 77 vs 10%) and lower median survival (24 vs 41 months, p = 0.02). Preoperative contact with PV/SMV, lymph node metastases, R1-direct margin and NO adjuvant chemotherapy were significantly associated with disease-specific survival at multivariate analysis.

conclusionPreoperative radiological tumour contact with PV/SMV in patients with NCCN resectable PDAC is associated with high rate of pathologic positive margins following surgery and poorer survival.

Indexed as

Mesenteric VeinsPancreatic NeoplasmsHumansNeoplasm InvasivenessPancreaticoduodenectomyPortal VeinRetrospective StudiesPancreatectomyPancreatic cancerPrognostic factorsSurgical margins

Identifiers

PMID33475833
OpenAlexW3123465480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.